Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 16,146 | 0 | 0 | 0 |
| Cost of Goods | N/A | 475 | N/A | 0 | 0 |
| Gross Profit | N/A | 15,671 | N/A | N/A | N/A |
| Operating Expenses | 20,032 | 21,751 | 17,767 | 25,354 | 18,121 |
| Operating Income | -20,032 | -5,605 | -17,767 | -25,354 | -18,121 |
| Other Income | 2,731 | 2,349 | 2,170 | 2,305 | 2,220 |
| Pre-tax Income | -17,301 | -3,256 | -15,597 | -23,049 | -15,901 |
| Net Income Continuous | -17,301 | -3,256 | -15,597 | -23,049 | -15,901 |
| Net Income | $-17,301 | $-3,256 | $-15,597 | $-23,049 | $-15,901 |
| EPS Basic Total Ops | -0.29 | -0.06 | -0.34 | -0.56 | -0.41 |
| EPS Basic Continuous Ops | -0.29 | -0.06 | -0.33 | -0.56 | -0.41 |
| EPS Diluted Total Ops | -0.29 | -0.06 | -0.34 | -0.56 | -0.41 |
| EPS Diluted Continuous Ops | -0.29 | -0.06 | -0.33 | -0.56 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.06 | -0.33 | N/A | N/A |
| EBITDA(a) | $-21,083 | $-5,777 | $-18,518 | $-26,311 | $-18,857 |